XML 67 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Payments (Tables)
12 Months Ended
Dec. 31, 2017
Compensation and Retirement Disclosure [Abstract]  
Schedule of share-based payments expense
    December 31,     December 31,  
    2017     2016  
Employees and directors share-based payments   $ 1,305,829     $ 319,718  
Schedule of stock option activity
   

Options
Outstanding

   

Weighted
Average
Exercise
Price

   

Weighted
Average
Remaining
Contractual
Life (Years)

   

Aggregated
Intrinsic
Value

 
Outstanding at January 1, 2017     2,101,428     $ 2.42       4.59     $ -  
Granted     733,200       4.34                  
Exercised     (258,455 )     1.83                  
Expired     (89,731 )     3.22                  
Forfeited     (633,051 )     2.81                  
Outstanding at December 31, 2017     1,853,391     $ 3.20       2.99     $ 0.02  
Vested and expected to be vested as of December 31, 2017     1,853,391     $ 3.20       2.99     $ 0.02  
                                 
Options exercisable at December 31, 2017 (vested)     1,662,591     $ 3.19       4.38     $ 0.03  
Schedule of assumptions used to estimate the fair values of the share options
    December 31,     December 31,  
    2017     2016  
Expected term      5.4 ~5.9 years        1.7 ~5.9 years    
Expected volatility      55% ~ 85 %      55% ~ 70 %
Expected dividend yield     0 %     0 %
Risk free interest rate      2.04% ~2.29 %      0.54% ~1.35 %
Schedule of warrants outstanding and exercisable
    2017     2016            
    Number of     Number of            
    Warrants     Warrants            
    Outstanding and     Outstanding and     Exercise     Expiration
Warrants Outstanding   Exercisable     Exercisable     Price     Date
                       
2012 August Financing Warrants (i)     -       536,250     $ 1.50     08/30/17
2013 Broker Warrants (Series D Financing)     -       228,571     $ 1.75     07/05/18
2013 Broker Warrants (Convertible Note)     -       114,285     $ 1.75     11/04/18
2014 Broker Warrants (Series E Financing)     703,714       1,085,714     $ 1.75     01/31/19
2016 Warrants to SSS (Note 12)     1,818,182       1,818,182     $ 2.75     03/28/18
      2,521,896       3,783,002              

 

(i) The warrants are classified as derivative liabilities as disclosed in Note 11.
Schedule of summary of restricted shares
    Shares     Weighted-average
fair value
 
Restricted shares outstanding at January 1, 2017     228,550     $ 1.75  
Granted     417,953       2.21  
Forfeited     (401,249 )     2.02  
Vested     (135,668 )     2.24  
Restricted shares outstanding at December 31, 2017     109,586       1.92